4/2024
vol. 16
Original paper
COMIRI – COMplexity Index of interventional Radiotherapy (brachytherapy) Implants: assessment of procedures based on type, equipment, and team
Valentina Lancellotta
1
,
Maria Antonietta Gambacorta
6, 7
,
- UOC Degenze di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
- UOC Fisica per le Scienze della Vita, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
- eCampus University, Novedrate (CO), Italy
- Brachytherapy Department, Maria Skłodowska-Curie National Research Institute of Oncology Gliwice Branch, Wybrzez.e Armii Krajowej, Gliwice, Poland
- Clinic of Radiotherapy, University Hospital of Schleswig-Holstein, Campus Kiel, Germany
- Università Cattolica del Sacro Cuore, Rome, Italy
- UOC Servizio di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
J Contemp Brachytherapy 2024; 16, 4: 306-309
Online publish date: 2024/09/20
Get citation
Interventional radiotherapy (IRT, brachytherapy) is a radiotherapy technique, in which radioactive sources are placed directly into or near the tumor site. IRT procedures are widely used in modern oncology, because they allow for treating different anatomical locations while delivering high doses and sparing the surrounding organs at risk [1]. Moreover, IRT is a procedure that requires several phases, which could be briefly classified as the clinical indication, implant, treatment planning, and delivery. Historically, several classification systems have been used for IRT, and they were based on the type of clinical purpose, type of implant and timing of the implant, dose-rate, and type of loading for treatment delivery. According to IRT clinical indication, it is possible to identify radical IRT when: 1. The aim of treatment is to cure, and IRT is delivered as the only treatment modality or as a boost to external beam radiotherapy [2]; 2. Post-operative purpose when IRT is employed after a surgical intervention to improve local control [3]; and 3. Palliative intent when the only reasonable clinical result expected is a reduction of clinical symptoms [4]. With regard to the type of implant, different types of IRT approaches can be distinguished, including contact [5], intra-cavitary [6], intra-luminal [7], and interstitial [8] techniques. Another way to classify the types of implants is to divide them into permanent or temporary implants [9]. In terms of dose-rate, low-dose-rate (LDR) [10], pul-sed-dose-rate (PDR) [11], or high-dose-rate (HDR) [12] can be classified. Specifically, LDR is defined as a dose of 0.4-2.0 Gray (Gy)/h, and HDR is identified as a dose of > 12 Gy/h [13], with typical irradiation distance. It is also important to emphasize that modern IRT mostly relies on remote afterloading units, which allow for significant decrease of radiation exposure on interventional radiation oncologists and radiation therapists [14, 15]. Another aspect to consider when classifying different IRT techniques is the overall number of catheters used to deliver the dose. In this regard, there are mono-catheter implants (for example, in adjuvant vaginal applicators where only the central channel is active) [7] or multi-catheter implants [8]. Finally, the role of anesthesiologist during the procedure is of paramount importance, since various procedures require local anesthesia (including spinal anesthesia), analgosedation, or general anesthesia [16]. In Table 1, the different classification systems are summarized according to phases of IRT process they are based on. Table 1Different classification systems used in interventional radiotherapy (brachytherapy) Phase | System |
---|
Indication | Radical, post-operative, palliative | Implant type | Contact, intra-cavitary, intra-luminal, interstitial | Implant timing | Permanent, temporary | Dose-rate | LDR, PDR, HDR | Simulation | RX, US, CT, MRI | Loading | Manual loading, remote afterloading | Number of catheters | Mono-catheter, multi-catheter | Anesthesiologist | Yes, No |
It is worth to underline that IRT has been recognized as a relevant part of modern oncology [17, 18], and is currently the subject of a huge interest, being used after a slow but inevitable decline in previous years [19]. The main reasons for such renewed interest in IRT are recent technological innovations, which have dramatically changed the clinical practice [20]. The first revolution occurred with the introduction of 3D image guidance for simulation and treatment planning [21]. The second point of paramount relevance is the launching of intensity-modulated external beam radiotherapy with dedicated 3D treatment planning systems in clinical practice, allowing for dose escalation and organ-sparing during EBRT [22]. These two technological advancements enabled discussions about image-guided and intensity-modulated IRT, respectively. To highlight the differences between the old technique and the new approach, some authors used a different naming, replacing “brachytherapy” with “interventional radiotherapy”. All the afore-mentioned classification systems are useful and currently implemented in the clinical practice. However, none of them consider the varying degree of complexity that characterizes interventional procedures. Specifically, IRT tools and strategies are continuously changing and updating. On the one hand, the role of image guidance is gaining more and more relevance [23], and on the other hand, the close and collaborative role of surgeons during some IRT procedures allows for safer and higher quality implants [24]. There are several aspects of interventional procedures regarding the complexity of implant phase, including the type of implant, imaging used during the procedure, and the role of multi-disciplinary team in operating room, as summarized in Table 1. Therefore, the implant complexity results from the combination of three different aspects: Type: As mentioned before, the type of implant may be contact, intra-cavitary, intra-luminal, or interstitial. The clinical and technical difficulties in the management of different types of implants are directly correlated with the expertise of interventional radiation oncologist. In addition, implants could be either based on single-catheter or multiple catheters. Equipment: The imaging used during implantation can be visual only (or requiring specific expertise, such as dermoscopy), and can rely on radiography, ultrasound, or CT, which are manageable by the radiation oncologist. Moreover, in selected cases, the imagining can require endoscopy (performed directly by IRT physician in selected centers only) or MRI. Team: This point is related to the need of a multi-disciplinary team in the operating room that, in addition to the interventional radiation oncologist, can comprise an anesthesiologist or, in certain circumstances, additional specialists, such as the surgeon to manage possible acute intra-operative complications, or medical physicist to support the implant procedure.
Based on the different procedural aspects, a system can be proposed to classify the complexity of procedures according to the overall score of the above-mentioned aspects of interventional procedures (Table 2), including the type of implant, primary imaging used during implantation, number of catheters, participation of an anesthesiologist, and multi-disciplinary team involvement. Table 2Different scores assigned according to the COMIRI system (scores are given in brackets) Type of implant | Contact (1) | Intracavitary (2) | Intraluminal (3) | Interstitial (4) |
---|
Primary imaging used during implant | Visual/cognitive (1) | RX (2) | US/CT (3) | Endoscopy/MRI (4) | Involvement of anesthesiologist | No (0) | Local/analgosedation (1) | General (2) | Number of catheters | Mono (1) | Multiple (2) | Interdisciplinary involvement during implant | No (0) | Yes (2) |
In Table 3, the scores of various typical procedures in commonly treated sites with four different degrees of complexity according to the scores with the following intervals, are presented: low (≤ 5), moderate (between 6 and 8), high (between 9 and 10), and very high (≥ 11). However, some clinics might use different approaches with diverse overall scores obtained for the same procedures. Table 3Complexity levels of implants in different anatomical sites | Type of implant | Imaging during implant | Anesthesiologist | No. of catheters | Multi-disciplinary involvement during implant | Overall score | Complexity |
---|
Vaginal cuff | 2 | 1 | 0 | 1 | 0 | 4 | Low | Skina | 1 | 1 | 0 | 2 | 0 | 4 | Cervixa | 2 | 3 | 0 | 2 | 0 | 7 | Moderate | Skinb | 4 | 1 | 1 | 2 | 0 | 8 | Cervixb | 4 | 3 | 1 | 2 | 0 | 10 | High | Anal canal | 4 | 3 | 1 | 2 | 0 | 10 | Breast | 4 | 3 | 1 | 2 | 0 | 10 | H&Nc | 4 | 1 | 2 | 2 | 2d | 11 | Very high | Uveal melanoma | 4 | 3 | 2 | 2e | 2f | 13 | Prostate | 4 | 3 | 2 | 2 | 2g | 13 |
It is absolutely fundamental to emphasize that the current proposal aimed at adequately framing a specific phase of IRT procedure, which is the implant. However, no association should be made between the complexity of implant and the complexity of subsequent phases. In fact, even contact skin radiotherapy that has a relatively low complexity implant is characterized by the same level of complexity regarding subsequent phases, relies on an accurate patient diagnosis, and both on imaging [25] and intensity modulation [26], in order to prevent toxicities [27]. There is a disparity in terms of access to IRT across different countries, and several domains should be empowered to foster the spread of this effective technique, including the clinical practice, education, research, and communication [28]. It is desirable that the correct understanding of the implant complexity can lead to changes in reimbursement systems, which may improve sustainability of IRT [29]. In addition, there are several dose calculation methods used in IRT. TG-43 relies on standardized data assuming a homogeneous medium, such as water, and is clinically validated. In contrast, TG-186 uses advanced algorithms to account for tissue heterogeneities and applicator characteristics, offering more accurate and personalized dose distributions. While TG-186 is not yet fully clinically validated, it should be further implemented to enhance dosimetric accuracy in brachytherapy [30]. In particular, the addition of the COMIRI classification system should adequately indicate the need for suitable resources according to the level of complexity for different IRT procedures in terms of personnel expertise, equipment availability, and multi-disciplinary teamwork. FundingThis research received no external funding. DisclosuresApproval of the Bioethics Committee was not required. ReferencesChargari C, Deutsch E, Blanchard P et al. Brachytherapy: An overview for clinicians. CA Cancer J Clin 2019; 69: 386-401. Tagliaferri L, Carra N, Lancellotta V et al. Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: single-institution experience. J Contemp Brachytherapy 2020; 12: 413-419. Harkenrider MM, Block AM, Alektiar KM et al. American Brachytherapy Task Group Report: Adjuvant vaginal brachy-therapy for early-stage endometrial cancer: A comprehensive review. Brachytherapy 2017; 16: 95-108. Jooya A, Talla K, Wei R et al. Systematic review of brachytherapy for symptom palliation. Brachytherapy 2022; 21: 912-932. Likhacheva AO, Devlin PM, Shirvani SM et al. Skin surface brachytherapy: A survey of contemporary practice patterns. Brachytherapy 2017; 16: 223-229. Fokdal L, Sturdza A, Mazeron R et al. Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study. Radiother Oncol 2016; 120: 434-440. Wortman BG, Astreinidou E, Laman MS et al.; PORTEC Study Group. Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer. Radiother Oncol 2021; 155: 160-166. Strnad V, Major T, Polgar C et al. ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost–GEC-ESTRO Breast Cancer Working Group practical recommendations. Radiother Oncol 2018; 128: 411-420. Skowronek J. Current status of brachytherapy in cancer treatment–short overview. J Contemp Brachytherapy 2017; 9: 581-589. Stish BJ, Davis BJ, Mynderse LA et al. Low dose rate prostate brachytherapy. Transl Androl Urol 2018; 7: 341-356. Pieters BR, Geijsen ED, Koedooder K et al. Treatment results of PDR brachytherapy combined with external beam radiotherapy in 106 patients with intermediate-to high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2011; 79: 1037-1042. Hoskin PJ, Colombo A, Henry A et al. GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update. Radiother Oncol 2013; 107: 325-332. International Commission on Radiation Units and Measurements (ICRU) Dose and volume specifications for reporting intracavitary therapy in gynecology. Bethesda, MD: ICRU, 1985. Whelan TJ, Aldrich JE, Voruganti SM et al. A comparison of manual and remote afterloading in the treatment of carcinoma of the cervix: increasing dose rate with a flexible applicator. Clin Oncol (R Coll Radiol) 1992; 4: 294-298. Aronowitz JN. Afterloading: The technique that rescued brachytherapy. Int J Radiat Oncol Biol Phys 2015; 92: 479-487. Roessler B, Six LM, Gustorff B. Anaesthesia for brachytherapy. Curr Opin Anaesthesiol 2008; 21: 514-518. Tree AC, Harding V, Bhangu A et al. The need for multidisciplinarity in specialist training to optimize future patient care. Nat Rev Clin Oncol 2017; 14: 508-517. Kovács G, Tagliaferri L, Valentini V. Is an Interventional Oncology Center an advantage in the service of cancer patients or in the education? The Gemelli Hospital and INTERACTS experience. J Contemp Brachytherapy 2017; 9: 497-498. Williams VM, Kahn JM, Thaker NG et al. The case for brachytherapy: Why it deserves a renaissance. Adv Radiat Oncol 2021; 6: 100605. Kovács G. Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy. J Contemp Brachytherapy 2015; 6: 404-416. Sturdza A, Pötter R, Fokdal LU et al. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol 2016; 120: 428-433. Callaghan CM, Adams Q, Flynn RT et al. Systematic review of intensity-modulated brachytherapy (IMBT): static and dynamic techniques. Int J Radiat Oncol Biol Phys 2019; 105: 206-221. Berger D, Van Dyk S, Beaulieu L et al. Modern tools for modern brachytherapy. Clin Oncol (R Coll Radiol) 2023; 35: e453-e468. Volz S, Kalousis K, Song JI et al. Brachytherapy in soft tissue tumours: an interdisciplinary challenge! Hell J Nucl Med 2017; 20 Suppl: 163. Yu L, Oh C, Shea CR. The treatment of non-melanoma skin cancer with image-guided superficial radiation therapy: An analysis of 2917 invasive and in situ keratinocytic carcinoma lesions. Oncol Ther 2021; 9: 153-166. Fionda B, Placidi E, Rosa E et al. Multilayer intensity modulated contact interventional radiotherapy (brachytherapy): Stretching the therapeutic window in skin cancer. J Contemp Brachytherapy 2023; 15: 220-223. Rembielak A. Complex and prolonged skin toxicity after superficial brachytherapy for basal cell carcinoma on the lower leg. J Contemp Brachytherapy 2020; 12: 406-411. Tagliaferri L, Vavassori A, Lancellotta V et al. Can brachytherapy be properly considered in the clinical practice? Trilogy project: The vision of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy study group. J Contemp Brachytherapy 2020; 12: 84-89. Swain M, Budrukkar A, Rembielak A et al. Challenges in the sustainability of brachytherapy service in contemporary radiotherapy. Clin Oncol (R Coll Radiol) 2023; 35: 489-496. Placidi E, Fionda B, Rosa E et al. Dosimetric impact of applying a model-based dose calculation algorithm for skin cancer brachytherapy (interventional radiotherapy). J Contemp Brachytherapy 2023; 15: 448-452.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License ( http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
|
|